Cargando…

DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome

Inhibiting the histone 3 lysine 79 (H3K79) methyltransferase, disruptor of telomeric silencing 1-like (DOT1L), increases the efficiency of reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Here, we find that, despite the enrichment of H3K79 methylation on thousands of actively t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wille, Coral K., Sridharan, Rupa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828533/
https://www.ncbi.nlm.nih.gov/pubmed/34995500
http://dx.doi.org/10.1016/j.stemcr.2021.12.004
_version_ 1784647868216246272
author Wille, Coral K.
Sridharan, Rupa
author_facet Wille, Coral K.
Sridharan, Rupa
author_sort Wille, Coral K.
collection PubMed
description Inhibiting the histone 3 lysine 79 (H3K79) methyltransferase, disruptor of telomeric silencing 1-like (DOT1L), increases the efficiency of reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Here, we find that, despite the enrichment of H3K79 methylation on thousands of actively transcribed genes in somatic cells, DOT1L inhibition (DOT1Li) does not immediately cause the shutdown of the somatic transcriptional profile to enable transition to pluripotency. Contrary to the prevalent view, DOT1Li promotes iPSC generation beyond the mesenchymal to epithelial transition and even from already epithelial cell types. DOT1Li is most potent at the midpoint of reprogramming in part by repressing Nfix that persists at late stages of reprogramming. Importantly, regulation of single genes cannot substitute for DOT1Li, demonstrating that H3K79 methylation has pleiotropic effects in maintaining cell identity.
format Online
Article
Text
id pubmed-8828533
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88285332022-02-14 DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome Wille, Coral K. Sridharan, Rupa Stem Cell Reports Article Inhibiting the histone 3 lysine 79 (H3K79) methyltransferase, disruptor of telomeric silencing 1-like (DOT1L), increases the efficiency of reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Here, we find that, despite the enrichment of H3K79 methylation on thousands of actively transcribed genes in somatic cells, DOT1L inhibition (DOT1Li) does not immediately cause the shutdown of the somatic transcriptional profile to enable transition to pluripotency. Contrary to the prevalent view, DOT1Li promotes iPSC generation beyond the mesenchymal to epithelial transition and even from already epithelial cell types. DOT1Li is most potent at the midpoint of reprogramming in part by repressing Nfix that persists at late stages of reprogramming. Importantly, regulation of single genes cannot substitute for DOT1Li, demonstrating that H3K79 methylation has pleiotropic effects in maintaining cell identity. Elsevier 2022-01-06 /pmc/articles/PMC8828533/ /pubmed/34995500 http://dx.doi.org/10.1016/j.stemcr.2021.12.004 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Wille, Coral K.
Sridharan, Rupa
DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title_full DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title_fullStr DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title_full_unstemmed DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title_short DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
title_sort dot1l inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828533/
https://www.ncbi.nlm.nih.gov/pubmed/34995500
http://dx.doi.org/10.1016/j.stemcr.2021.12.004
work_keys_str_mv AT willecoralk dot1linhibitionenhancespluripotencybeyondacquisitionofepithelialidentityandwithoutimmediatesuppressionofthesomatictranscriptome
AT sridharanrupa dot1linhibitionenhancespluripotencybeyondacquisitionofepithelialidentityandwithoutimmediatesuppressionofthesomatictranscriptome